Olema Pharmaceuticals, Inc.
Clinical trials sponsored by Olema Pharmaceuticals, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced breast cancer: OP-1250 faces off against standard care Results expected Oct 2026 (estimated)
- New cancer drug OP-3136 enters first human tests Results expected May 2027 (estimated)